These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy. Guazzi MD, Qing LG, Olivari MT, Fiorentini C, Loaldi A, Bartorelli A, Moruzzi P, Polese A. Acta Med Scand Suppl; 1982 Jul; 659():233-50. PubMed ID: 6127892 [Abstract] [Full Text] [Related]
12. A comparison of the hemodynamic effects of prenalterol and isoprenaline in patients with complete heart block. Svendsen TL, Pelle H, Lønholt C, Bonde J, Kampmann JP, Lindeneg O. J Cardiovasc Pharmacol; 1984 Jul; 6(4):693-6. PubMed ID: 6206327 [Abstract] [Full Text] [Related]
14. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure. Currie PJ, Kelly MJ, Middlebrook K, Federman J, Sainsbury E, Ashley J, Pitt A. Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784 [Abstract] [Full Text] [Related]
15. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease. Svendsen TL, Carlsen JE, Hartling OJ, Trap-Jensen J. Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993 [Abstract] [Full Text] [Related]